References
- BijlsmaJWBerenbaumFLafeberFPOsteoarthritis: an update with relevance for clinical practiceLancet20113772115212621684382
- PereiraDPeleteiroBAraújoJBrancoJSantosRARamosEThe effect of osteoarthritis definition on prevalence and incidence estimates: a systematic reviewOsteoarthritis Cartilage2011191270128521907813
- Centers for Disease Control and PreventionOsteoarthritis (OA)2015 Available from: http://www.cdc.gov/arthritis/basics/osteoarthritis.htmAccessed January 30, 2016
- JordanKMArdenNKDohertyMEULAR recommendations 2003:an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Ann Rheum Dis2003621145115514644851
- HochbergMCAltmanRDAprilKTAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care Res201264465474
- ZhangWMoskowitzRWNukiGOARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidenceOsteoarthritis Cartilage200715981100017719803
- ZhangWMoskowitzRWNukiGOARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis Cartilage20081613716218279766
- ZhangWNukiGMoskowitzRWOARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009Osteoarthritis Cartilage20101847649920170770
- McAlindonTEBannuruRRSullivanMCOARSI guidelines for the non-surgical management of knee osteoarthritisOsteoarthritis Cartilage20142236338824462672
- National Collaborating Centre for Chronic ConditionsOsteoarthritis: National Clinical Guidelines for Care and Management in AdultsLondonRoyal College of Physicians2008
- National Institute for Health and Care ExcellenceOsteoarthritis: Care and ManagementLondonNICE2014
- MooreNDiclofenac potassium 12.5 mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safetyClin Drug Investig200727163195
- MooreNCharlesworthAVan GanseERisk factors for adverse events in analgesic drug users: results from the PAIN studyPharmacoepidemiol Drug Saf20031260161014558184
- MooreNVan GanseELe ParcJParacetamol, Aspirin and Ibuprofen New tolerability study. A large scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesiaClin Drug Investig1999188998
- SchafferDFlorinTEagleCRisk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic reviewMed J Aust200618550150617137455
- SinghGWuOLanghornePMadhokRRisk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysisArthritis Res Ther20068R15316995929
- WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of non-steroidal antiinflammatory drugsN Engl J Med19993401888189910369853
- SingerFOberleitnerHEin Beitrag zur medikamentösen Therapie der aktivierten Arthrose. Zur Effektivität eines Enzymgemisches vs. Diclofenac [Drug therapy of activated arthrosis: on the effectiveness of an enzyme mixture versus diclofenac]Wien Med Wochenschr19961465558 German8867274
- SingerFSingerCOberleitnerHPhlogenzym versus diclofenac in the treatment of activated osteoarthritis of the knee: a double-blind prospective randomized studyInt J Immunother200117135141
- AkhtarNMNaseerRFarooqiAZAzizWNazirMOral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee: a double-blind prospective randomized studyClin Rheumatol20042341041515278753
- KleinGKullichWShort-term treatment of painful osteoarthritis of the knee with oral enzymes: a randomized, double-blind study versus diclofenacClin Drug Investig2000191523
- HerreraEGPhlogenzym in the treatment of a monoarticular painful gonarthritis: efficacy and tolerance1998 Available from: http://www.wobenzym.cz/cdweb/mucos/pittompg.htmAccessed June 12, 2016
- RothSHStauderGMOral enzyme therapy (Phlogenzym) in osteoarthritis: long-term comparative study against diclofenacPoster presented at: 65th Annual Scientific Meeting of the American College of RheumatologyNovember 11–15, 2001San Francisco, CA
- BoltenWWGladeMJRaumSRitzBWThe safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trialArthritis2015201525152125802756
- International Union of BiochemistryNomenclature Committee: Enzyme NomenclatureLondonAcademic Press1984
- OCR Systeme GmbHFormPro 3.0: Data capture from forms and questionnaires Available from: http://www.ocr-systeme.de/english/formproAccessed June 12, 2016
- US Food Drug AdministrationGuidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA)1999 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071577.pdfAccessed June 12, 2016
- European Medicines AgencyGuideline on clinical investigation of medicinal products used in the treatment of osteoarthritis2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003440.pdfAccessed June 12, 2016
- LequesneMGThe algofunctional indices for hip and knee osteoarthritisJ Rheumatol1997247797819101517
- MedDRA [website on the Internet] Available from: http://www.meddra.orgAccessed January 16, 2016
- BellamyNCarrADougadosMSheaBWellsGTowards a definition of “difference” in osteoarthritisJ Rheumatol20012842743011246691
- TubachFRavaudPBaronGEvaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvementAnn Rheum Dis200564293315208174
- EngelsJMDiehrPImputation of missing longitudinal data: a comparison of methodsJ Clin Epidemiol20035696897614568628
- McKnightPEMcKnightKMSidaniSFigueredoAJMissing Data: A Gentle IntroductionNew YorkGuilford Press2007
- DemirtasHHedekerDAn imputation strategy for incomplete longitudinal ordinal dataStat Med2008274086409318338313
- HolmSA simple sequentially rejective multiple test procedureScand Stat Theory Appl197966570
- GailMSimonRTesting for qualitative interactions between treatment effects and patient subsetsBiometrics1985413613724027319
- HedgesLVOlkinIStatistical Methods for Meta-analysisOrlandoAcademic Press1985
- DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
- DerSimonianRLairdNMeta-analysis in clinical trials revisitedContemp Clin Trials20154513914526343745
- LightRJPillemerDBSumming Up: The Science of Reviewing ResearchCambridge (MA)Harvard University Press1984
- EggerMSmithGDSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ19973156296249310563
- SterneJAEggerMFunnel plots for detecting bias in meta-analysis: guidelines on choice of axisJ Clin Epidemiol2001541046104511576817
- MoskowitzRWThe burden of osteoarthritis: clinical and quality-of-life issuesAm J Manag Care200915S223S22919817508
- GuccioneAAFelsonDTAndersonJJThe effects of specific medical conditions on the functional limitations of elders in the Framingham studyAm J Public Health1994843513588129049
- JordanJLutaGRennerJDragomirAHochbergMFryerJKnee pain and knee osteoarthritis severity in self-reported task specific disability: the Johnston County Osteoarthritis ProjectJ Rheumatol199724134413499228135
- van DijkGMVeenhofCSchellevisFComorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or kneeBMC Musculoskelet Disord200899518582362
- SpectorTDHartDJNandraDLow-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive diseaseArthritis Rheum1997407237279125256
- PelletierJPMartel-PelletierJAbramsonSBOsteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targetsArthritis Rheum2001441237124711407681
- WarnerTDGiulianoFVojnovicIBukasaAMitchellJAVaneJRNonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisProc Natl Acad Sci U S A1999967563756810377455
- SychaTGustorffBLehrSTanewAEichlerHGSchmettererLA simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjectsBr J Clin Pharmacol20035616517212895189
- ChenYFJobanputraPBartonPCyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluationHealth Technol Assess2008121278iii
- NiculescuLLiCHuangJMallenSPooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDsCurr Med Res Opin20092572974019210159
- MukherjeeDNissenSETopolEJRisk of cardiovascular events associated with selective COX-2 inhibitorsJAMA200128695495911509060
- NüeschEDieppePReichenbachSWilliamsSIffSJüniPAll cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort studyBMJ2011342d116521385807
- AntmanEMBennettJSDaughertyAFurbergCRobertsHTaubertKAUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation20071151634164217325246
- AltmanRDPractical considerations for the pharmacologic management of osteoarthritisAm J Manag Care200915S236S24319817510
- MazourovVILilaAMKlimkoNNRaimuevKVMakulovaTGThe efficacy of systemic enzyme therapy in the treatment of rheumatoid arthritisInt J Immunother1997138591
- FriedrichFTherapie der chronischen Adnexitis: Diclofenac oder Enzyme? Randomisierte doppelblinde Parallelgruppenstudie gegen DiclofenacAllgemeinarzt19931710611064
- LackovicVRovenskyJHorvathováMMalisFInterferon production in whole blood cultures from volunteers and rheumatoid arthritis patients after medication with oral enzymesInt J Immunother199713159165
- VaneJRInhibition of prostaglandin synthesis as mechanism of action for aspirin-like drugsNat New Biol19712312322355284360
- VaneJRBottingRMNew insights into mode of action of anti-inflammatory drugsInflamm Res1995441107664022
- VaneJRBottingRMMechanism of action of nonsteroidal anti-inflammatory drugsAm J Med1998104S2S8
- LivioMBertoniMPDeGaetanoGEffect of bromelain on fibrinogen level, prothrombin complex factors and platelet aggregation in the rat: a preliminary reportDrugs Exp Clin Res197844953
- MetzigCGrabowskaEEckertKRehseKMaurerHRBromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivoIn Vivo19991371210218125
- MaurerHRBromelain: biochemistry, pharmacology and medical useCell Mol Life Sci2001581234124511577981
- BraunJMSchneiderBBeuthHJTherapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS® in children with acute sinusitis in GermanyIn Vivo20051941742115796206
- FitzhughDJShanSDewhirstMWHaleLPBromelain treatment decreases neutrophil migration to sites of inflammationClin Immunol2008128667418482869
- OnkenJEGreerPKCalingaertBHaleLPBromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsiesIn Vitro Clin Immunol200812634535218160345
- McLeanPGAstonDSarkarDAhluwaliaAProtease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury – involvement of lipoxygenase products, VR1 receptors, and C-fibersCirc Res20029046547211884377
- ReedCEKitaHThe role of protease activation of inflammation in allergic respiratory diseasesJ Allergy Clin Immunol2004114997100815536399
- NeumayerCFüglANanobashviliJCombined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscleJ Surg Res200613315015816458926
- PagonisCTauberAIPavlotskyNSimonsERFlavonoid impairment of neutrophil responseBiochem Pharmacol1986352372453002387
- KuoSMDietary flavonoid and cancer prevention: evidence and potential mechanismCrit Rev Oncog1997847699516086
- BazzanoLAHeJOgdenLGFruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey epidemiologic follow-up studyAm J Clin Nutr200276939912081821
- LotitoSBFreiBConsumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?Free Radic Biol Med2006411727174617157175
- BögerRHSchmidtGAntirheumatika und AntiphlogistikaSchwabeUPaffrathDArzneiverordnungs – Report 2014HeidelbergSpringer2014
- KleinGKullichWSchnitkerJSchwannHEfficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip: a double-blind, randomized study comparing oral enzymes with non-steroidal anti-inflammatory drugsClin Exp Rheumatol200624253016539815
- RothSHFullerPPooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or olderClin Interv Aging2012712713722791985
- CiccolunghiSNChaudriHASchubigerBIReddropRReport on a long-term tolerability study of up to two years with diclofenac sodium (Voltaren)Scand J Rheumatol Suppl1978228696
- GrossnerTSmythEMFitzgeraldGAAnti-inflammatory, antipyretic, and analgesic agents: pharmacotherapy of goutBruntonLLChabnerBAKnollmanBCGoodman and Gilman’s: The Pharmacological Basis of Therapeutics12th edNew YorkMcGraw-Hill20119591004
- LewisJHStineJGNonsteroidal anti-inflammatory drugs and leukotriene receptor antagonists: pathology and clinical presentation of hepatotoxicityKaplowitzNDeLeveLDDrug-Induced Liver Disease3rd edAmsterdamElsevier201370402
- LaineLGoldkindLCurtisSPConnorsLGYanqiongZCannonCPHow common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trialAm J Gastroenterol200910435636219174782
- de AbajoFJMonteroDMadurgaMGarcía RodríguezLAAcute and clinically relevant drug-induced liver injury: a population based case-control studyBr J Clin Pharmacol200458718015206996
- AithalGPDayCPNonsteroidal anti-inflammatory drug-induced hepatotoxicityClin Liver Dis20071156357517723920
- American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc2009571331134619573219
- JonesRNonsteroidal anti-inflammatory drug prescribing: past, present, and futureAm J Med20011101A4S7S11165987
- RothSHFullerPDiclofenac topical solution compared with oral diclofenac: a pooled safety analysisJ Pain Res2011415916721811391
- LichtenbergerLMThe hydrophobic barrier properties of gastrointestinal mucusAnnu Rev Physiol1995575655837778878
- LichtenbergerLMWhere is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisitedBiochem Pharmacol20016163163711266647
- SmecuolEBaiJCSugaiEAcute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugsGut20014965065511600467
- LaineLConnorsLGReicinASerious lower gastrointestinal clinical events with nonselective NSAID or coxib useGastroenterology200312428829212557133
- GoldsteinJLEisenGMLewisBGralnekIMZlotnickSFortJGVideo capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placeboClin Gastroenterol Hepatol2005313314115704047
- SmecuolESanchezMISuarezALow-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessmentClin Gastroenterol Hepatol2009752452919249402
- LaineLSmithRMinKChenCDuboisRWSystematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugsAliment Pharmacol Ther20062475176716918879
- LanasAGarcía-RodríguezLAPolo-TomásMTime trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practiceAm J Gastroenterol20091041633164119574968
- KleinGKullichWSchwannHDouble-blind trial of an enzyme therapy versus oral gold in rheumatoid arthritisClinicum199528
- KovalenkoVBShubaNMGolovatskiyIVBortkevichOPYasinskayaVAEstimation of efficacy of basic therapy of rheumatoid arthritis on the basis of systemic enzyme therapy: results of five-year monitoringInt J Immunother200117129133
- PázAZaborskiJKruszewska-OzimowskaJCzłonkowskiACzłonkowskaAAnalysis of peripheral blood leukocyte immunophenotype during oral hydrolytic enzyme treatment of multiple sclerosis patientsInt J Immunother2002181319